Changing lives through better vision.

Binocular Vision Dysfunction (BVD) is diagnosed and treated. Under his leadership, NeuroVisual Medicine is changing lives by improving visual alignment through groundbreaking microprism technology, enabling patients to feel better, function better, and live better.
With a vision to bring BVD awareness and treatment to tens of millions worldwide, Matt has overseen the growth of a global network of NeuroVisual specialists and the development of innovative solutions that empower optometrists to offer transformative care. His passion for driving patient care forward is rooted in his family legacy of optometric practice ownership and his commitment to advancing the NeuroVisual Family of Businesses.
Today, NeuroVisual Medicine continues to revolutionize the eyecare industry by combining proven patient screening, real-time diagnostic protocols, and precision microprism lens manufacturing. Under Matt’s leadership, the company is poised to make a lasting impact on the lives of millions globally, as it strives to bring relief to the nearly 1-in-5 people suffering from BVD.

" data-bs-avatar="https://vision-specialists.com/wp-content/uploads/2024/10/matt.png">

Binocular Vision Dysfunction (BVD) and Vertical Heterophoria (VH) in 1995. BVD and VH have been found to cause headaches, dizziness, gait imbalance, anxiety, light sensitivity, neck pain, and reading difficulties in approximately 1-in-5 patients. She and her colleagues at Vision Specialists of Michigan have treated more than 20,000 BVD/VH patients with microprism lenses and noise-canceling devices, of which half have been TBI / ABI patients. Her research (presented nationally and internationally) demonstrates that TBI patients with VH experiencing persistent post-concussive symptoms have 80% reduction in these symptoms when treated with microprism lenses and noise-canceling devices.

Since 2013, over 70 optometrists have successfully completed the NeuroVisual Medicine Training Program™ and have gone on to help tens of thousands of patients. Drs. Feinberg and Rosner’s founding of the NeuroVisual Medicine Institute is led by their mission to increase access to NeuroVisual care for patients in every region across the globe.

" data-bs-avatar="https://vision-specialists.com/wp-content/uploads/2024/10/debby.png">

Binocular Vision Dysfunction (BVD) research since 2005, and in 2010, Dr. Rosner co-founded the NeuroVisual Medicine Institute with Dr. Feinberg.  His research efforts have led to the validation of the Binocular Vision Dysfunction Questionnaire (BVDQ™) and co-authorship of peer-reviewed articles on the connection between BVD and TBI.  Dr. Rosner has presented lectures on the topic of BVD and microprism treatment nationally and internationally.
Dr. Rosner’s work on refining the NeuroVisual Medicine™ business model has enabled over 40 practices world-wide to add a meaningful profit center to their clinics, while transforming the lives of optometrists and their patients.

" data-bs-avatar="https://vision-specialists.com/wp-content/uploads/2024/10/mark.png">